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Recent studies showed that injection of interleukin (IL)-
12 prevents ultraviolet (UV) light mediated suppression
of contact hypersensitivity and breaks UV-induced hapten
specific tolerance. UV-mediated suppression can be
adoptively transferred by injecting splenocytes from UV-
irradiated mice; however, suppression is not transferable
when donor mice are treated with IL-12 after UV-
irradiation. This study was performed to elucidate the
mechanisms by which IL-12 counteracts this immuno-
suppression. To characterize the cells transferring sup-
pression, depletion studies were performed revealing that
UV-induced suppression is transferred via CD81 T cells.
To investigate whether IL-12 counteracts UV-induced
suppression by either inhibiting the development of CD81
suppressor T cells or inducing CD41 effector T cells,
splenocytes from mice, which were IL-12 treated and
sensitized through UV-exposed skin, were depleted from
Cutaneous exposure to UV light impairs the inductionof contact hypersensitivity (CHS) to haptens applieddirectly to the irradiated skin surface in certain strainsof mice and in humans (Toews et al, 1980; Streileinand Bergstresser, 1988; Cooper et al, 1992). Moreover,
animals sensitized through UV-exposed skin develop hapten specific
tolerance, because these mice cannot be resensitized against the same
hapten several weeks later, even if it is applied on another previously
not UV-exposed skin area. Apparently, this tolerance is due to the
development of T cells with hapten-specific suppressor activity, because
adoptive transfer of these T cells into naı¨ve, syngeneic mice abrogates
the CHS response to the respective hapten in the recipient animals
(Elmets et al, 1983).
Interleukin (IL)-12 is a recently described heterodimeric cytokine
composed of covalently linked 35 kDa and 40 kDa subunits (Chehimi
and Trinchieri, 1994). Besides its stimulatory effects on both natural
killer cells (Kobayashi et al, 1989) and cytotoxic T lymphocytes (Stern
et al, 1990), IL-12 has costimulatory and regulatory effects on T helper
cells. Recently, IL-12 was found to be critically involved in the
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CD41 T cells and transferred into naı¨ve mice that were
subsequently sensitized. Whereas transfer of splenocytes
from UV-irradiated mice inhibited sensitization of recipi-
ents, no inhibition was observed after transfer of spleno-
cytes from UV-exposed and IL-12 treated mice.
Recipients that received CD4 depleted spleen cells from
UV-exposed and IL-12 treated donors, were still fully
sensitizable. IL-12 also blocked transfer of UV-induced
suppression when it was injected into UV-exposed donor
animals at a time point when suppressor cells had already
developed. CD4 depletion of such splenocytes did not
result in a loss of the reconstitutive effect of IL-12. This
suggests that IL-12 may break UV-induced tolerance not
by inducing CD41 effector T cells, but rather by inhibiting
or inactivating suppressor T cells belonging to the CD8
subtype. Key words: suppressor cells/tolerance/transfer. J Invest
Dermatol 110:272–276, 1998
development of Th1 cells. In particular, IL-12 induces Th1-specific
immune responses and inhibits the development of Th2 cells in vitro
(Manetti et al, 1993, 1994; Hsie et al, 1993; Wu et al, 1993). These
in vitro observations have been confirmed in vivo, where IL-12 was
able to induce Th1-specific immune responses in mice infected with
Leishmania (Sypeck et al, 1993; Reiner et al, 1994; Heinzel et al, 1993).
Moreover, we have recently shown that IL-12 plays a critical role in
CHS, because in vivo neutralization of IL-12 inhibits the induction of
CHS and also induces hapten-specific tolerance (Rieman et al, 1996).
Furthermore, we and others (Mu¨ller et al, 1995; Schwarz et al, 1996)
have reported that mice can be sensitized by applying haptens to low
dose UV-exposed skin, if IL-12 is injected i.p. between UV-irradiation
and hapten application, suggesting that IL-12 can prevent local UV-
induced immunosuppression. Even more importantly, mice that were
intially tolerized by hapten application through UV-exposed skin also
produced a significant CHS reaction when they received rIL-12 just
before resensitization with the same hapten. This indicated that IL-12
does not only prevent UV-induced immunosuppression but also breaks
UV-induced hapten specific tolerance (Mu¨ller et al, 1995; Schwarz
et al, 1996). Whereas adoptive transfer of spleen and lymph node cells
from UV-treated mice inhibited subsequent sensitization of the recipient
mice, transfer of cells from UV-irradiated mice treated with rIL-12
had no effect on the CHS response in recipients (Schwarz et al, 1996).
In a similar fashion, but using the systemic model of UV-induced
immunosuppression, Schmitt et al (1995) reported that IL-12 prevents
the induction of suppressor T cells, because adoptive transfer of spleen
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cells from UV-irradiated mice treated with IL-12 had no effect on the
immune response of the recipient mice, whereas transfer of spleen cells
from UV-irradiated mice treated with the vehicle inhibited the immune
response. Although the adoptive transfer of UV-induced suppressor T
cells from irradiated mice suppressed the immune response of the
recipient mice, treatment of recipient mice with IL-12 following the
adoptive transfer overcame the immune suppression. Schmitt et al
(1995) concluded from these data that IL-12 can overcome UV-
induced immune suppression by preventing the induction, as well as
neutralizing the capacity, of preformed suppressor T cells; however,
this study (Schmitt et al, 1995) and our transfer experiments reported
recently (Schwarz et al, 1996) do not exclude the possibility that IL-
12 might counteract UV-induced immunosuppression, not by affecting
T suppressor cells but by just enhancing the activity of T effector cells
that may enable subsequent sensitization.
Here, we show that tolerance induced by UV light is mediated via
induction of CD81 suppressor T cells. To investigate whether IL-12
overcomes tolerance by inhibiting CD81 suppressor T cells or by
activating CD41 effector T cells, splenocytes from UV-exposed, hapten
treated, and IL-12 injected mice were depleted from CD41 T cells
and transferred into naı¨ve mice that were subsequently sensitized.
Because recipients receiving CD4 depleted splenocytes from UV-
irradiated and IL-12 treated mice were fully sensitizable, we conclude
that IL-12 may break UV-induced tolerance by acting on (presumably
inhibiting) CD81 T cells rather than by activating CD41 T cells.
MATERIALS AND METHODS
Contact hypersensitivity C3H/HeN mice (8–10 wk old) were purchased
from Charles River Deutschland (Sulzfeld, Germany). Mice were sensitized by
painting 25 µl of 2,4,-dinitrofluorobenzene (DNFB, Sigma, St. Louis, MO)
solution (0.5% in acetone:olive oil, 4:1) on the shaved back on day 0 as
described (Schwarz et al, 1994). On day 5, 20 µl 0.3% DNFB was applied to
the left ear, and acetone:olive oil was applied to the right ear. Ear swelling was
quantitated with a spring-loaded micrometer (Mitutoyo, Japan) 24 h after
challenge. CHS was determined as the amount of swelling of the hapten-
challenged ear compared with the thickness of the vehicle-treated ear in
sensitized animals and expressed in cm 3 10–3 (mean 6 SD). Mice that
were ear-challenged without prior sensitization served as negative controls.
Resensitization was performed as described above through abdominal skin 14 d
after the first challenge. Second challenge was performed on the right ear 5 d
after second sensitization. Each group consisted of at least seven mice, and each
experiment was performed at least three times.
UV irradiation The shaved back was exposed to UV light from a bank of
four FS-20 fluorescent lamps (Westinghouse Electric, Pittsburgh, PA) that emit
most of their energy within the UVB range (290–320 nm) with an emission
peak at 313 nm. The UV output measured at 310 nm using an IL1700 research
radiometer (International Light, Newburyport, MA) was 7.5 W per m2 at a
tube to target distance of 25 cm. Mice were exposed to UVB daily for four
consecutive days (1000 J per m2 per exposure). Twenty-four hours after the
last UV exposure, DNFB was applied carefully to the surface of the irradiated
area as described above. As reported previously (Schwarz et al, 1996), the UV
regimen applied does not cause systemic immunosuppression, but induces
hapten specific tolerance (Grabbe et al, 1996).
Injection of rIL-12 Recombinant murine IL-12 was kindly provided by
S. Wolf (Genetics Insitute, Cambridge, MA). For in vivo injection, rIL-12 was
diluted in sterile endotoxin-free saline and injected i.p. (1000 ng). Control
mice were treated intraperitoneally with equal volumes of saline, which had
no effect on the outcome of the sensitization procedure or on the suppressive
effect of UV exposure.
Adoptive transfer of immune response Donor mice were treated as
indicated, spleens and regional lymph nodes were removed thereafter, and
single-cell suspensions prepared. Cell number was adjusted to 2.5 3 108 cells
per ml and 200 µl were injected intravenously into each recipient mouse.
Recipients were sensitized 24 h later by epicutaneous application of DNFB on
the shaved back. After 5 d, mice were challenged on the left ear and ear
swelling was evaluated 24 h later.
Subpopulation depletion For in vitro depletion of subpopulations, cells were
incubated with rat anti-mouse CD4 monoclonal antibody (clone GK 1.5) or
anti-CD8 monoclonal antibody (clone 53.6; both from Becton Dickinson, San
Jose, CA) at a final dilution of 1:100 for 1 h at 4°C. The cells were washed
Figure 1. Transfer of UV-induced suppression is mediated via CD81 T
cells. Mice were sensitized on the back with DNFB and ear challenge with
DNFB performed 5 d later. Negative control mice were ear challenged only
(group 6). Twenty-four hours before sensitization, groups 1–4 were injected
intravenously with 5 3 107 spleen and lymph node cells obtained from
syngeneic donor animals. Donors were either left untreated (group 1) or sensitized
through UV-exposed skin (groups 2–4). Cells for transfer were obtained 5 d
after sensitization of donor animals and immediately transferred into recipient
animals. Cells to be transferred were left untreated (groups 1 and 2), or depleted
either from CD41 (group 3) or CD81 T cells (group 4). Twenty-four hours
after transfer recipient mice were sensitized against DNFB, ear challenge
performed 5 d later, and ear swelling measured 24 h later. Ear swelling response
is expressed as the difference (cm 3 10–3, mean 6 SD) between the thickness
of the challenged ear compared with the thickness of the vehicle-treated ear.
*p , 0.001 versus positive control (group 5).
three times with RPMI 1640 medium to remove fetal calf serum and incubated
with magnetic beads coated with sheep anti-rat IgG (Dynal, Hamburg, Germany)
for 1 h at 4°C. Thereafter, tubes were placed in a magnetic field and the
residual cells collected. Residual cells were washed twice by centrifugation, and
5 3 107 cells were injected intravenously into recipients as described above.
The efficacy of depletion was determined by flow cytometry (EPICS XL,
Coulter, Miami, FL).
Statistical analysis Data were analyzed by Student’s t test and differences
were considered significant at p , 0.05. Each experiment was performed at
least three times.
RESULTS
UV-induced suppression of CHS can be transferred by CD81
T cells To elucidate the mechanism of how IL-12 counteracts UV-
induced immunosuppression, we first characterized the cells by which
UV-induced suppression is transferred. Spleen and regional lymph node
cells from C3H/HeN mice sensitized 5 d earlier by topical application
of DNFB onto UV-exposed skin were injected intravenously into
naı¨ve syngeneic mice. Before transfer, the cells were depleted or not
depleted by in vitro treatment with monoclonal antibodies to either
CD4 or CD8, followed by removal of positive cells with magnetic
beads coupled with sheep anti-rat IgG. Depletion was very efficient
(less than 1% residual contaminating cells), as confirmed by flow
cytometric analysis (data not shown). Recipients were sensitized with
DNFB 24 h after transfer, their ears were challenged 5 d later, and ear
swelling was measured 24 h thereafter. As previously reported (Schwarz
et al, 1996), the CHS response in mice receiving unfractionated cells
from sensitized UV-treated mice was remarkably suppressed (Fig 1,
group 2), when compared with mice that were just sensitized and
challenged (Fig 1, group 5) or with recipients that received spleen and
lymph node cells from untreated donors (Fig 1, group 1). A similar
degree of suppression was transferred by the cell preparations depleted
of CD41 cells (Fig 1, group 3), whereas the preparations depleted of
CD81 cells did not inhibit subsequent sensitization (Fig 1, group 4).
Thus, the T cells mediating tolerance in local UV-induced immunosup-
pression appear to belong to the CD81 subset.
There is an ongoing, still unresolved debate about whether CD41
or CD81 cells mediate CHS. Although studies by Hauser (1990),
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Figure 2. CD41 T cells mediate CHS. Mice were sensitized on the back
with DNFB, 5 d later spleen and lymph node cells were obtained. Cell
suspensions were left untreated (Undepl.) or depleted from CD41 cells (CD4-
depl.) and from CD81 cells (CD8-depl.), respectively. Cell suspensions were
injected intravenously into naı¨ve mice and recipients were ear challenged 24 h
later. Ear swelling response measured 24 h after challenge is expressed as the
difference (cm 3 10–3, mean 6 SD) between the thickness of the challenged
ear compared with the thickness of the vehicle-treated ear. *p , 0.0001 versus
undepleted group.
Anderson et al (1995), and Kondo et al (1996) regard CD41 T cells as
the critical effector cells of CHS, Gocinski and Tigelaar (1990), Bour
et al (1995), and Xu et al (1996) provide evidence that CD81 T cells
are important. Based on these controversial findings, for the scope of
this study it appeared advantageous to determine whether CD41 or
CD81 T cells mediate CHS in the model used. To address this issue,
mice were sensitized with DNFB, and spleen and lymph node
suspensions were obtained 5 d after sensitization and depleted of either
CD41 or CD81 cells. Cell suspensions were injected intravenously
into naı¨ve mice that were ear challenged 24 h after transfer. Recipients
receiving undepleted cells from sensitized donors responded with a
significant ear swelling response in comparison with control mice
(Fig 2). In contrast, no CHS reaction was observed upon transfer of
CD4-depleted cells, whereas animals receiving CD8-depleted lymph
node cells reacted with a pronounced ear swelling response. Taken
together, these data suggest that CD41 cells are primarily responsible
for mediating the effector phase of our CHS model.
Both prevention of transferable suppression and reversal of UV-
induced tolerance by IL-12 are not mediated through an effect
on CD41 T cells Cells from mice that were injected intraperitoneally
with 1 µg rIL-12 3 h before sensitization through UV-exposed skin,
did not transfer immunosuppression (Fig 3, group 2), confirming our
previously reported data (Schwarz et al, 1996). As IL-12 may affect
both CD41 and CD81 T cells, it might restore the immune response
in the above described model either by inhibiting the development of
CD81 suppressor cells or by inducing CD41 effector cells that might
overcome the inhibitory activity of suppressor cells. To test whether
IL-12 restores the immune response by acting on CD41 or CD81
cells, donor mice were UV-exposed, IL-12 treated, and subsequently
sensitized with DNFB through UV-exposed skin as described above.
Spleen and lymph node cells were obtained 5 d after sensitization and
transferred to naı¨ve mice after depletion or not of CD41 cells. As
shown in Fig 3, no suppression was observed transferring either total
(group 2) or CD41-depleted cells from IL-12-treated animals (group 3),
which suggests that the restoring effect of IL-12 is not mediated via
CD41 cells.
We recently reported that IL-12 does not only prevent immunosup-
pression when injected before sensitization through UV-exposed skin,
but it also reverses already induced transferable suppression when
injected before resensitization (Schwarz et al, 1996), suggesting that
IL-12 is also effective when suppressor cells have already developed.
Figure 3. Prevention of transferable suppression by IL-12 does not
depend on CD41 T cells. Mice were sensitized on the back with DNFB
and ear challenge with DNFB was performed 5 d later (groups 1–4). Negative
control mice were ear challenged only (group 5). Twenty-four hours before
sensitization, groups 1, 2, and 3 were injected intravenously with 5 3 107 spleen
and lymph node cells obtained from syngeneic donor animals. Donors were
sensitized through UV-exposed skin (group 1) or treated with IL-12 between
UV exposure and sensitization (groups 2 and 3). Cells for transfer were obtained
5 d after sensitization of donor animals. Cell suspensions were left untreated
(groups 1 and 2) or depleted from CD4 cells (group 3). Recipient animals were
sensitized 24 h after transfer and ears challenged 5 d later. Ear swelling response
is expressed as the difference (cm 3 10–3, mean 6 SD) between the thickness
of the challenged ear compared with the thickness of the vehicle-treated
ear. *p , 0.001.
Figure 4. Breaking of UV-induced tolerance by IL-12 is not mediated
via CD41 cells. Mice were sensitized on the back with DNFB and ear
challenge with DNFB was performed 5 d later (groups 1–4). Negative control
mice were ear challenged only (group 5). Twenty-four hours before sensitization,
groups 1–3 were injected intravenously with 5 3 107 spleen and lymph node
cells obtained from syngeneic donor animals. Donors were sensitized through
UV-exposed skin and resensitized 10 d later (groups 1–3). Groups 2 and 3
received 1000 ng IL-12 i.p. before resensitization. Splenocytes and lymph node
cells were obtained 5 d after resensitization of donor animals. Cell suspensions
were left untreated (groups 1 and 2) or depleted from CD4 cells (group 3).
Recipient animals were sensitized 24 h after transfer and ear challenged 5 d
later. Ear swelling response is expressed as the difference (cm 3 10–3, mean
6 SD) between the thickness of the challenged ear and that of the ear measured
immediately before challenge. *p , 0.005.
To test whether IL-12 breaks transferable suppression by affecting
CD81 or CD41 cells, spleen and lymph node cells, depleted or not
depleted of CD41 cells, from donor mice sensitized through UV-
exposed back skin and, 2 wk later, resensitized against DNFB through
abdominal skin that was not UV-exposed, were transferred into normal
recipients. One group of donor mice was treated with IL-12 3 h
before resensitization. Transfer of cells from mice treated with IL-12
(Fig 4, group 2), unlike those from untreated mice (group 1), did not
result in impaired sensitization of donor mice. Again, the reconstitutive
effect of IL-12 injected into donor animals before resensitization was
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not affected by CD4 depletion (Fig 4, group 3), suggesting that the
reconstitutive effect of IL-12 is not mediated via CD41 cells.
DISCUSSION
UV radiation, in particular UVB (290–320 nm), has suppressive effects
on the immune system that appear to be relevant to UV-induced
carcinogenesis and to UV-induced exacerbation of infectious diseases
(Kripke, 1990; Streilein et al, 1994; Chapman et al, 1994). Depending
on the mouse strains used and the time lag between UV exposure and
sensitization (Noonan and DeFabo, 1990), UV radiation can induce
either local immunosuppression, limited to the area of skin exposed to
UV light (Toews et al, 1980), or a systemic form of immunosuppression
inhibiting the generation of delayed type hypersensitivity and CHS
responses induced at distant unirradiated skin areas (Jessup et al, 1978;
Noonan et al, 1981). Although the mechanisms underlying UV-induced
systemic and local immunosuppression appear to differ significantly,
both types of immune suppression inhibit the induction of contact and
delayed type hypersensitivity and induce hapten specific tolerance.
Because hapten specific suppression can be adoptively transferred into
normal recipient mice in both systems, development of T cells with
suppressor activity appears to be of major importance. Recently, it was
shown in both the local (Mu¨ller et al, 1995; Schwarz et al, 1996) and
the systemic model (Schmitt et al, 1995) that sensitization can be
restored in UV-irradiated mice upon treatment with rIL-12. As transfer
of splenocytes from UV-irradiated mice treated with IL-12 had no
effect on the immune response of the recipient mice, one can speculate
that IL-12 prevents UV-induced immunosuppression by inhibiting
development of T cells with suppressor activity (Mu¨ller et al, 1995;
Schmitt et al, 1995; Schwarz et al, 1996). IL-12 not only prevents
induction of tolerance, but can also break UV-induced tolerance,
because injection of IL-12 into successfully tolerized mice enables
sensitization against the respective hapten (Mu¨ller et al, 1995; Schwarz
et al, 1996). In those studies, IL-12 was injected when T suppressor
cells had developed because transfer of suppression is already possible
at that time point, suggesting that IL-12 can neutralize the activity of
preformed suppressor T cells (Schmitt et al, 1995).
While inhibition of the development of suppressor T cells is rather
easy to understand, it is difficult to explain how IL-12 should inactivate
already developed T suppressor cells. Thus, an alternative explanation
for the reversal of tolerance might be induction of T effector cells
that may overcome the activity of suppressor cells and thus enable
sensitization in tolerized mice. This possibility is supported by the
observation that suppressor T cells can be present in mice that display
a normal CHS response (Glass et al, 1990). Because this possibility has
not been excluded in previous studies (Schmitt et al, 1995; Schwarz
et al, 1996), we were interested in clarifying by which of these
mechanisms IL-12 breaks tolerance. In several tolerance models, transfer
of suppression is mediated via CD41 suppressor cells (Ullrich et al,
1990; Yagi et al, 1996); however, Steinbrink et al (1996) have recently
shown in the model of low zone tolerance that transfer of suppression
is entirely due to CD81 T cells. Taken together, these studies indicate
that both CD41 and CD81 T cells can transfer suppression depending
on the tolerance model used. In the systemic form of UV-induced
suppression, transfer of tolerance is mediated by the induction of
antigen-specific, CD31, CD41, and CD8– suppressor cells (Ullrich
et al, 1990). In the local form of UV-induced immunosuppression,
Elmets et al (1983) showed that treatment of cells from UV-irradiated
animals with antibodies directed against Lyt-1 (CD5) completely
abrogated their ability to transfer suppression, whereas treatment of
cells with antibodies directed against Lyt-2 (CD8) partially inhibited
suppression (Elmets et al, 1983). To the best of our knowledge, since
that time these studies have never been repeated with antibodies
directed against CD4 and CD8, respectively. In our model of local
UV-induced suppression, transfer of in vitro depleted spleen and lymph
node cells revealed that tolerance was transferred by the fraction
depleted of CD41 T cells, whereas the fraction depleted of CD81 T
cells did not inhibit subsequent sensitization. Thus, the T cells mediating
suppression in our model of local UV-induced suppression were shown
to belong to the CD81 subtype.
Next, we analyzed whether IL-12 prevents and reverts UV-induced
immunosuppression by affecting CD81 or CD41 T cells. As already
reported previously (Schwarz et al, 1996), transfer of cells from UV-
irradiated donor mice that were treated with IL-12 before hapten
application on the UV-exposed skin area, did not inhibit subsequent
sensitization of the recipients. Furthermore, as postulated by Schmitt
et al (1995), for systemic immunosuppression, IL-12 is able to revert
the activity of already developed suppressor T cells when injected
immediately before resensitization at a time when transferable suppres-
sion can already be demonstrated. Depletion of CD41 cells from the
transferred cells did not affect the ability of IL-12 treatment to either
prevent transferable suppression or revert already activated suppressor
cells. Thus, our data suggest that IL-12 may inhibit both the generation
and the activity of CD81 suppressor T cells, presumably by a direct
effect; however, because IL-12 is injected into intact donor animals
we cannot exclude that IL-12 acts in these mice on CD41 T cells or
natural killer cells that ultimately may inhibit CD81 cells responsible
for the transfer of suppression in this system. Furthermore, because we
did not purify CD81 cells but just depleted CD41 cells, we cannot
exclude that other cell types (CD4–, CD8–) present in the CD4-
depleted cell suspensions may also play a role.
There is increasing evidence that CD81 cells, similar to CD41 cells,
can be divided in type 1 cells (Tc1) releasing IFN-γ and lymphotoxin
and type 2 cells (Tc2) secreting IL-4 (Fong and Mosmann, 1990; Seder
et al, 1992). Low zone tolerance to contact allergens appears to be
mediated via CD81 Tc2 cells (Steinbrink et al, 1996); however, Xu
et al (1996) reported that CHS is mediated via CD81 Tc1 cells, whereas
CD41 Th2 cells exhibit inhibitory activity, an observation that supports
findings by Gocinski and Tigelaar (1990) that depletion of CD41 cells
before sensitization results in enhanced ear swelling response, and by
Bour et al (1995) that major histocompatibility complex class I deficient
mice are unable to mount a CHS response to DNFB. The interpretation
of these observations appears unclear, because they are in sharp contrast
to previous and recent findings identifying CD41 T cells as the critical
effector cells for CHS (Hauser, 1990; Anderson et al, 1995; Kondo
et al, 1996). In our hands, depletion of CD41 cells resulted in a loss
of transfer of CHS. Upon depletion of CD81 cells the ear swelling
response of recipient animals was slightly decreased in comparison with
mice receiving undepleted cells, the differences, however, were never
significant. Consequently, our data indicate CD41 T cells as the critical
effector cells and thus are in accordance with the findings of Hauser
(1990), Kondo et al (1996), and Anderson et al (1995). The critical
role of CD41 cells in our CHS model is also confirmed by our own
preliminary data showing that major histocompatibility complex class
I deficient mice do not have an impaired CHS response (S. Grabbe,
unpublished observations). One explanation for the controversial
findings may be the use of slightly different CHS models, e.g., Xu
et al (1996) sensitized the mice by applying the hapten twice on the
shaved abdomen and on the footpads, whereas Kondo et al (1996)
used the more classical method of painting the hapten just once on
razor shaved skin, as we did in this study. Nevertheless, using the
CD8-mediated CHS model, DiIulio et al (1996) could show that
application of IL-12 is able to induce CD41 effector cells. This effect,
however, does not explain the tolerance breaking activity of IL-12,
because as shown in Fig 4 the restoring effect of IL-12 is not affected
by depletion of CD41 cells. Although this study demonstrates that the
final target for IL-12 to break UV-induced tolerance are not CD41,
but rather CD81 T cells, based on the findings by Xu et al (1996) one
could argue that IL-12 might break UV-induced tolerance in our
model by inducing CD81 Tcl cells, and not by inhibiting CD81 T
suppressor cells. CD4 depletion of splenocytes and lymph nodes from
UV- and IL-12-treated donors, of course, does not allow us to
distinguish between these two possibilities, and CD8 depletion would
not add any further information, because this treatment would abrogate
the CD81 suppressor T cells.
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